======= TBX18 =======
== Gene Information ==
* **Official Symbol**: TBX18
* **Official Name**: T-box transcription factor 18
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9096|9096]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O95935|O95935]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TBX18&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX18|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604613|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This genes codes for a member of an evolutionarily conserved family of transcription factors that plays a crucial role in embryonic development. The family is characterized by the presence of the DNA-binding T-box domain and is divided into five sub-families based on sequence conservation in this domain. The encoded protein belongs to the vertebrate specific Tbx1 sub-family. The protein acts as a transcriptional repressor by antagonizing transcriptional activators in the T-box family. The protein forms homo- or heterodimers with other transcription factors of the T-box family or other transcription factors. [provided by RefSeq, Nov 2012].
* **UniProt Summary**: Acts as transcriptional repressor involved in developmental processes of a variety of tissues and organs, including the heart and coronary vessels, the ureter and the vertebral column. Required for embryonic development of the sino atrial node (SAN) head area. {ECO:0000250|UniProtKB:Q9EPZ6, ECO:0000269|PubMed:26235987}.
|T-box|
|regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation|
|negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation|
|Tle3-Aes complex|
|RNA polymerase II activating transcription factor binding|
|somitogenesis|
|transcription regulatory region sequence-specific DNA binding|
|somite development|
|cell fate specification|
|segmentation|
|regulation of embryonic development|
|morphogenesis of embryonic epithelium|
|negative regulation of canonical Wnt signaling pathway|
|negative regulation of Wnt signaling pathway|
|anterior/posterior pattern specification|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|cell fate commitment|
|regulation of canonical Wnt signaling pathway|
|renal system development|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|urogenital system development|
|regionalization|
|regulation of Wnt signaling pathway|
|morphogenesis of an epithelium|
|pattern specification process|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|protein heterodimerization activity|
|tissue morphogenesis|
|embryonic morphogenesis|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|negative regulation of transcription by RNA polymerase II|
|protein homodimerization activity|
|anatomical structure formation involved in morphogenesis|
|negative regulation of developmental process|
|embryo development|
|regulation of anatomical structure morphogenesis|
|epithelium development|
|negative regulation of transcription, DNA-templated|
|negative regulation of multicellular organismal process|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of signal transduction|
|negative regulation of RNA metabolic process|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|negative regulation of response to stimulus|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|tissue development|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.75|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15014
* **Expression level (log2 read counts)**: -2.17
{{:chemogenomics:nalm6 dist.png?nolink |}}